Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC Investigating CVS Caremark Business Practices

Executive Summary

A campaign orchestrated by the National Community Pharmacists Association to have the Federal Trade Commission investigate the business practices of CVS Caremark has borne fruit: the company says it is under investigation

You may also be interested in...



CVS Caremark To Pay FTC $5 Million To Resolve First Medicare Part D Deceptive Pricing Case

The Federal Trade Commission claims a CVS subsidiary posted prices for Rx drugs at CVS and Walgreens pharmacies that were as much as ten times less than the actual prices, pushing consumers into the donut hole more quickly.

CVS Caremark CEO Merlo Dispels Talk Of Company Breakup

Despite lagging performance, Merlo says PBM poised for healthy financial performance in 2012.

Rep. Lynch Pushes PBM Transparency Bill For Federal Benefits; OPM Resists

Congressional efforts to mandate transparency rules for pharmacy benefit managers working in the Federal Employees Health Benefits Program are meeting with some resistance from top officials at the Office of Personnel Management, the agency that oversees FEHBP

Related Content

Topics

UsernamePublicRestriction

Register

PS051650

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel